ArticleDiscover oncology2026

A bortezomib resistance-related gene signature predicts prognosis, with ARID5B downregulation associated with poor overall survival in multiple myeloma.

Yangyang Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.